Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tesetaxel for Previously Treated Patients With Bladder Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Genta Incorporated.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Genta Incorporated
ClinicalTrials.gov Identifier:
NCT01215877
First received: October 5, 2010
Last updated: July 9, 2012
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)